Product
PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
2 clinical trials
2 indications
Indication
Diabetic Macular EdemaIndication
Diabetic RetinopathyClinical trial
A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Macular Edema (Pagoda)Status: Active (not recruiting), Estimated PCD: 2022-09-19
Clinical trial
A Phase III, Multicenter, Randomized Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic RetinopathyStatus: Active (not recruiting), Estimated PCD: 2022-10-03